TABLE 4

Characteristics of Deceased Patients With KD

PatientAgeNo. of IVIG DosesMethylprednisolonePrednisoloneWarfarinEnoxaparinNo. of Tissue Plasminogen Activator DosesTime From First Admission to Death, dOther Pertinent Diagnoses
13 y1YesYesYesYes347Cardiac arrest; mitral valve disorder
211 y3YesNoNoYes082Other shock without mention of trauma
35 mo2YesNoNoNo24CAA; coronary artery occlusion without myocardial infarction
45 y1NoNoNoNo01Cardiac arrest; coronary artery occlusion without myocardial infarction; mitral valve disorder
51.7 y2YesYesNoNo029Cardiac arrest; CAA
61.5 y3YesNoNoNo1102Myocarditis; acute myocardial infarction, unspecified site, initial episode of care